60 Degrees Pharmaceuticals Net Income

SXTP Stock   4.01  0.10  2.43%   
As of the 10th of February, 60 Degrees owns the Coefficient Of Variation of 2233.26, standard deviation of 20.47, and Market Risk Adjusted Performance of 0.2215. In connection with fundamental indicators, the technical analysis model gives you tools to check timely technical drivers of 60 Degrees Pharmaceu, as well as the relationship between them.

60 Degrees Total Revenue

708,169

Analyzing historical trends in various income statement and balance sheet accounts from 60 Degrees' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting 60 Degrees' valuation are summarized below:
Gross Profit
585.9 K
Market Capitalization
5.4 M
Enterprise Value Revenue
11.4637
Revenue
1.4 M
Earnings Share
(3.10)
There are currently one hundred twenty fundamental measures for 60 Degrees that can be evaluated and compared over time across peers in the sector. Investors and active traders are advised to validate 60 Degrees' latest fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 02/10/2026, Enterprise Value is likely to drop to about 1.6 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-7.2 M-7.5 M
Net Loss-5.6 M-5.8 M
Net Loss-7.2 M-7.5 M
Net Loss(80.42)(76.40)
Net Income Per E B T 1.15  1.10 
As of 02/10/2026, Net Loss is likely to drop to about (7.5 M). In addition to that, Net Loss is likely to drop to about (5.8 M).
  
Build AI portfolio with SXTP Stock
Evaluating 60 Degrees's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into 60 Degrees Pharmaceuticals's fundamental strength.

Latest 60 Degrees' Net Income Growth Pattern

Below is the plot of the Net Income of 60 Degrees Pharmaceuticals over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in 60 Degrees Pharmaceu financial statement analysis. It represents the amount of money remaining after all of 60 Degrees Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is 60 Degrees' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 60 Degrees' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (7.96 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

SXTP Net Income Regression Statistics

Arithmetic Mean(4,128,228)
Coefficient Of Variation(43.97)
Mean Deviation1,459,041
Median(3,033,744)
Standard Deviation1,814,977
Sample Variance3.3T
Range4.9M
R-Value(0.78)
Mean Square Error1.4T
R-Squared0.60
Significance0.0002
Slope(279,477)
Total Sum of Squares52.7T

SXTP Net Income History

2026-7.5 M
2025-7.2 M
2024-7.9 M
2023-3.8 M
2022-6.2 M
2021-4.3 M

Other Fundumenentals of 60 Degrees Pharmaceu

60 Degrees Net Income component correlations

SXTP Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for 60 Degrees is extremely important. It helps to project a fair market value of SXTP Stock properly, considering its historical fundamentals such as Net Income. Since 60 Degrees' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 60 Degrees' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 60 Degrees' interrelated accounts and indicators.
Can Pharmaceuticals industry sustain growth momentum? Does SXTP have expansion opportunities? Factors like these will boost the valuation of 60 Degrees. If investors know SXTP will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating 60 Degrees demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(3.10)
Revenue Per Share
2.946
Quarterly Revenue Growth
2.569
Return On Assets
(0.70)
Return On Equity
(1.55)
The market value of 60 Degrees Pharmaceu is measured differently than its book value, which is the value of SXTP that is recorded on the company's balance sheet. Investors also form their own opinion of 60 Degrees' value that differs from its market value or its book value, called intrinsic value, which is 60 Degrees' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because 60 Degrees' market value can be influenced by many factors that don't directly affect 60 Degrees' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 60 Degrees' value and its price as these two are different measures arrived at by different means. Investors typically determine if 60 Degrees is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, 60 Degrees' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

60 Degrees 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 60 Degrees' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 60 Degrees.
0.00
11/12/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/10/2026
0.00
If you would invest  0.00  in 60 Degrees on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding 60 Degrees Pharmaceuticals or generate 0.0% return on investment in 60 Degrees over 90 days. 60 Degrees is related to or competes with CNS Pharmaceuticals, Calidi Biotherapeutics, Silo Pharma, Can Fite, Clearmind Medicine, GRI Bio, and Kazia Therapeutics. 60 Degrees is entity of United States. It is traded as Stock on NASDAQ exchange. More

60 Degrees Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 60 Degrees' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 60 Degrees Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

60 Degrees Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for 60 Degrees' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 60 Degrees' standard deviation. In reality, there are many statistical measures that can use 60 Degrees historical prices to predict the future 60 Degrees' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 60 Degrees' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.193.8625.31
Details
Intrinsic
Valuation
LowRealHigh
0.367.1928.64
Details
1 Analysts
Consensus
LowTargetHigh
16.0217.6019.54
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-3.15-3.15-3.15
Details

60 Degrees February 10, 2026 Technical Indicators

60 Degrees Pharmaceu Backtested Returns

60 Degrees appears to be dangerous, given 3 months investment horizon. 60 Degrees Pharmaceu retains Efficiency (Sharpe Ratio) of 0.0463, which signifies that the company had a 0.0463 % return per unit of price deviation over the last 3 months. By evaluating 60 Degrees' technical indicators, you can evaluate if the expected return of 0.99% is justified by implied risk. Please makes use of 60 Degrees' Standard Deviation of 20.47, coefficient of variation of 2233.26, and Market Risk Adjusted Performance of 0.2215 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, 60 Degrees holds a performance score of 3. The firm owns a Beta (Systematic Risk) of 4.28, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 60 Degrees will likely underperform. Please check 60 Degrees' information ratio, as well as the relationship between the value at risk and kurtosis , to make a quick decision on whether 60 Degrees' current price history will revert.

Auto-correlation

    
  -0.65  

Very good reverse predictability

60 Degrees Pharmaceuticals has very good reverse predictability. Overlapping area represents the amount of predictability between 60 Degrees time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 60 Degrees Pharmaceu price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current 60 Degrees price fluctuation can be explain by its past prices.
Correlation Coefficient-0.65
Spearman Rank Test-0.65
Residual Average0.0
Price Variance1.46
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

SXTP Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

110,227

At this time, 60 Degrees' Accumulated Other Comprehensive Income is relatively stable compared to the past year.
Based on the recorded statements, 60 Degrees Pharmaceuticals reported net income of (7.96 Million). This is 102.33% lower than that of the Pharmaceuticals sector and 111.36% lower than that of the Health Care industry. The net income for all United States stocks is 101.39% higher than that of the company.

SXTP Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 60 Degrees' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 60 Degrees could also be used in its relative valuation, which is a method of valuing 60 Degrees by comparing valuation metrics of similar companies.
60 Degrees is currently under evaluation in net income category among its peers.

60 Degrees ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 60 Degrees' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 60 Degrees' managers, analysts, and investors.
Environmental
Governance
Social

SXTP Fundamentals

About 60 Degrees Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze 60 Degrees Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 60 Degrees using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 60 Degrees Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with 60 Degrees

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 60 Degrees position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 60 Degrees will appreciate offsetting losses from the drop in the long position's value.

Moving against SXTP Stock

  0.6BAC Bank of AmericaPairCorr
  0.59GE GE Aerospace Sell-off TrendPairCorr
  0.56BKNG Booking HoldingsPairCorr
  0.55AA Alcoa CorpPairCorr
  0.46MRK Merck CompanyPairCorr
The ability to find closely correlated positions to 60 Degrees could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 60 Degrees when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 60 Degrees - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 60 Degrees Pharmaceuticals to buy it.
The correlation of 60 Degrees is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 60 Degrees moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 60 Degrees Pharmaceu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 60 Degrees can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for SXTP Stock Analysis

When running 60 Degrees' price analysis, check to measure 60 Degrees' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 60 Degrees is operating at the current time. Most of 60 Degrees' value examination focuses on studying past and present price action to predict the probability of 60 Degrees' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 60 Degrees' price. Additionally, you may evaluate how the addition of 60 Degrees to your portfolios can decrease your overall portfolio volatility.